|
BioBasel
News
Wednesday, August 27, 2008
BASEL, Switzerland - The National Institute for Health and Clinical Excellence (NICE) has recommended Lucentis® (ranibizumab) as a cost-effective therapy for all eligible patients with wet age-related macular degeneration (AMD), an eye disease that is the leading cause of blindness in people over the age of 50....
Click the title to read the full article
Wednesday, August 27, 2008
BASEL, Switzerland / WALKERSVILLE – Lonza announces the availability of primary Clonetics® Adult Normal Human Epidermal Melanocytes. These are highlycharacterized cells for use in diverse applications in dermal research including malignant melanoma, dermal disorders, toxicology, pigmentation and cosmetic studies....
Click the title to read the full article
Wednesday, August 27, 2008
BASEL, Switzerland - Novartis announced today that Glivec®
(imatinib)* has been granted priority review status by the US Food
and Drug Administration (FDA) as the first therapy to be reviewed for
use after surgery in kit-positive gastrointestinal stromal tumors
(GIST). ...
Click the title to read the full article
Wednesday, August 27, 2008
Agilent is committed to being an economic, intellectual and social asset to each nation and community in which it operates. As such, Agilent and its foundation support the efforts of the Clean Air Challenge (CAC) program to promote environmental sustainability through science education. Most recently, Agilent has helped extend this program in India....
Click the title to read the full article
Wednesday, August 27, 2008
The Siegfried Group (SWX: SFZN) announces sales in its continuing Divisions of CHF 318.3 million for the 2007 fiscal year, an increase of 6.2% over the previous year. Both Divisions of the Group improved their position and continued on their growth course. The EBITDA of the continued Divisions amounted to CHF 69 mil-lion, an increase over 2006 (CHF 66.4 million). Reported net income of CHF 49.7 million is clearly above the previous year’s level. ...
Click the title to read the full article
Wednesday, August 27, 2008
MILFORD, Mass., USA - Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the Thermo Scientific HERAcell i Series of cell culture CO2 incubators....
Click the title to read the full article
Wednesday, August 27, 2008
HEERLEN, The Netherlands - DSM N.V., the global Life Sciences and Materials Sciences Company headquartered in the Netherlands, today announces the closure of its citric acid manufacturing plant in Wuxi (China) by Q1 2009....
Click the title to read the full article
Wednesday, August 27, 2008
HEERLEN, The Netherlands - DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announces that it has acquired an equity stake of 29.3% in Provexis plc, an AIM listed company that develops and licenses ingredients for the functional food, medical food and dietary supplement market. ...
Click the title to read the full article
Tuesday, August 26, 2008
MECHELEN, Belgium and CAMBRIDGE, UK – Galapagos NV (Euronext: GLPG) and Sareum Holdings plc (AIM: SAR) announce today that Galapagos has acquired Sareum’s assets in drug discovery services, for a total cash consideration of €695,000 (£553,000). ...
Click the title to read the full article
Tuesday, August 26, 2008
Genzyme Corp. (Nasdaq: GENZ), a global leader in biotechnology, and Medicines for Malaria Venture (MMV), a not-for-profit virtual research and development (R&D) organization dedicated to reducing the burden of malaria, announced today a new collaboration with India’s Advinus Therapeutics Ltd. ...
Click the title to read the full article
Tuesday, August 26, 2008
CARLSBAD, CA, USA - Invitrogen Corporation (NASDAQ:IVGN) today announced it has set the date for a special meeting of its shareholders, to consider the proposed acquisition of Applied Biosystems Inc. ...
Click the title to read the full article
Tuesday, August 26, 2008
BASEL, Switzerland, - Approval of Actelion Ltd's Tracleer for use in a fatal lung disease could double sales of its biggest drug, the biotech company's chief executive told Reuters....
Click the title to read the full article
Tuesday, August 26, 2008
BETHESDA, MD, USA - Sucampo Pharmaceuticals, Inc., today announced that it has named Kathryn de Santis as its Vice President, Investor Relations and Corporate Communications....
Click the title to read the full article
Tuesday, August 26, 2008
Now a new class of so-called "Swiss Army Knife drugs" has emerged that treat an array of oft-unrelated ills. They include Centocor's Remicade, Abbott Labs' Humira, Pfizer's Lyrica, Amgen's Enbrel and Eli Lilly's Cymbalta. The same pill can treat conditions as varied as depression or diabetic nerve pain....
Click the title to read the full article
Tuesday, August 26, 2008
CHICAGO, IL, USA - According to the CDC, an influenza pandemic could infect 30 percent of the overall American population -- that's 1,057,731 to 1,586,697 residents in Cook County alone. ...
Click the title to read the full article
Tuesday, August 26, 2008
WALTHAM, Mass., USA - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will present at the Thomas Weisel Partners Healthcare Conference, being held at the Four Seasons Hotel in Boston. The company will present on Thursday, September 4, 2008, at 9:10 am (EDT)....
Click the title to read the full article
Monday, August 25, 2008
INDIANAPOLIS, USA - Data from a new study suggest that Cymbalta (duloxetine HCl) 60-120 mg once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) 24-hour average pain score, compared with placebo....
Click the title to read the full article
Monday, August 25, 2008
MILAN, Italy – Newron Pharmaceuticals S.p.A. (“Newronâ€), a research and development company focused on novel CNS and pain therapies, today reports that it has received confirmation from SWX Swiss Exchange Ltd., that the Company will be included in the SXI Life Sciences and the SXI Bio+Medtech indices effective September 22, 2008. ...
Click the title to read the full article
Monday, August 25, 2008
Tobacco is better known as a cause of cancer rather than a potential cure. But scientists in Arizona and elsewhere believe tobacco plants may hold the key to developing a personalized cancer vaccine as well as treatments for other diseases....
Click the title to read the full article
Monday, August 25, 2008
LinkMed’s wholly owned subsidiary Olerup SSP AB has developed a new test that detects genetic variations in the Human Leucocyte Antigen (HLA) system that indicate risk for severe adverse reactions to Abacavir in HIV patients. The test is marketed and sold by Qiagen. Experts expect more tests for similar markers in the future....
Click the title to read the full article
1
|
|
|
|
|